Mark Openshaw

University Hospitals Birmingham NHS Foundation Trust

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Naureen Starling

Reader

Institute of Cancer Research

UNITED KINGDOM

View details

Rodrigo Toledo

Miguel Servet Researcher (Assistant Professor)

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mark Openshaw

Research Interests

Explore related searches

Contact this professor

Articles (12)

Evaluation of two Massive Open Online Courses (MOOCs) in genomic variant interpretation for the NHS workforce.

Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials.

Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologists

P-113 Evidence for early detection of metastatic variants and tumour evolution in ctDNA of patients with oesophageal adenocarcinoma

Taxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immunopathogenesis.

Mismatch Repair Screening of Gastrointestinal Cancers: The Impact on Lynch Syndrome Detection and Immunotherapy.

Sensitive screening of single nucleotide polymorphisms in cell free DNA for diagnosis of gestational tumours.

New Frontiers in the Medical Therapy of Hepatocellular Carcinoma.

Longitudinal whole-exome sequencing of cell-free DNA for tracking the co-evolutionary tumor and immune evasion dynamics: longitudinal data from a single patient

Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease.

Increased emergency presentation of new lung cancer diagnoses and less treatment: a COVID legacy

Back from the brink: EGFR inhibition in gastroesophageal cancer.

Collaborators (2)

Naureen Starling

Rodrigo Toledo

Make your next move.